acitretin

The drug is used for the symptomatic treatment of exceptionally severe skin keratinization disorders, such as psoriasis (including erythrodermic and pustular forms), ichthyosis, Darier's disease, De Vergie's disease, lichen planus, and abnormal skin thickening on the palms and soles.

Form: capsules, hard

ATC: D05BB02

Manufacturer: mibe GmbH Pharmaceuticals Sun-Farm Sp. z o.o.

The drug is used for the symptomatic treatment of exceptionally severe skin keratinization disorders, such as psoriasis (including erythrodermic and pustular forms), abnormal thickening of the skin on the palms and soles, ichthyosis, Darier's disease, Devergie's disease, and lichen planus of the skin and mucous membranes.

Form: capsules, hard

ATC: D05BB02

Manufacturer: mibe GmbH Pharmaceuticals Sun-Farm Sp. z o.o.

The medicine is used to treat severe skin diseases in which the skin becomes thick and may peel. This includes, among others, psoriasis, ichthyosis, erythroderma, and keratosis follicularis (Darier's disease).

Form: capsules

ATC: D05BB02

Manufacturer: Cenexi Roche Poland Sp. z o.o.

The medicine is used to treat severe skin diseases in which the skin becomes thick and may peel. This includes, among others, psoriasis, ichthyosis, erythroderma, and keratosis follicularis (Darier's disease).

Form: capsules

ATC: D05BB02

Manufacturer: Cenexi Roche Poland Sp. z o.o.